169 related articles for article (PubMed ID: 34414496)
1. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
Wessendorf J; König A; Heers H; Mahnken AH
Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
Park BK; Kim CK; Park SY; Shen SH
Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
[TBL] [Abstract][Full Text] [Related]
3. Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results.
Iwamoto Y; Kanda H; Yamakado K; Soga N; Arima K; Takeda K; Sugimura Y
Fam Cancer; 2011 Sep; 10(3):529-34. PubMed ID: 21503747
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
[TBL] [Abstract][Full Text] [Related]
6. [Radiofrequency ablation for recurred renal cell carcinoma in the solitary kidney due to von Hippel-Lindau disease--indication and tip on how to prevent the thermal injury of the adjacent organs].
Anai H; Nagata T; Sato T; Minoshima K; Horie M; Yoshiya K; Uchida H; Kichikawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2303-5. PubMed ID: 21224555
[TBL] [Abstract][Full Text] [Related]
7. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study.
Chan VW; Lenton J; Smith J; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Lewington A; Kimuli M; Cartledge J; Wah TM
Eur J Surg Oncol; 2022 Mar; 48(3):672-679. PubMed ID: 34728141
[TBL] [Abstract][Full Text] [Related]
8. [Conservative therapy by percutaneous radiofrequency ablation of renal cell carcinomas--therapeutic experiments of four patients with seven renal tumors--].
Karashima T; Inoue K; Shimamoto T; Yamasaki I; Kamada M; Shuin T
Hinyokika Kiyo; 2006 Apr; 52(4):241-7. PubMed ID: 16686349
[TBL] [Abstract][Full Text] [Related]
9. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].
Nao T; Shimamoto T; Karashima T; Kamei M; Fukuhara H; Fukata S; Satake H; Ashida S; Yamasaki I; Kamata M; Inoue K; Yamanishi T; Ogawa Y; Ito S; Shuin T
Hinyokika Kiyo; 2014 Sep; 60(9):415-20. PubMed ID: 25293793
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Combined Embolization and Radiofrequency Ablation in Stage 1 Renal Cell Carcinomas.
Wessendorf J; König AM; Heers H; Mahnken AH
Rofo; 2022 Sep; 194(9):1020-1025. PubMed ID: 35272357
[TBL] [Abstract][Full Text] [Related]
13. Laser navigation for radiofrequency ablation.
Varro Z; Locklin JK; Wood BJ
Cardiovasc Intervent Radiol; 2004; 27(5):512-5. PubMed ID: 15383857
[TBL] [Abstract][Full Text] [Related]
14. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
[TBL] [Abstract][Full Text] [Related]
15. CT-guided radiofrequency ablation of a renal tumor abutting vascular pedicle in a patient with von Hippel Lindau disease.
Park BK; Kim CK
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):840-2. PubMed ID: 19067041
[No Abstract] [Full Text] [Related]
16. Patterns of intervention for renal lesions in von Hippel-Lindau disease.
Matin SF; Ahrar K; Wood CG; Daniels M; Jonasch E
BJU Int; 2008 Sep; 102(8):940-5. PubMed ID: 18485044
[TBL] [Abstract][Full Text] [Related]
17. Incidence of multiple sporadic renal cell carcinomas in patients referred for renal radiofrequency ablation: implications for imaging follow-up.
Beland MD; Wolf FJ; Grand DJ; Dupuy DE; Mayo-Smith WW
AJR Am J Roentgenol; 2011 Sep; 197(3):671-5. PubMed ID: 21862810
[TBL] [Abstract][Full Text] [Related]
18. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
[TBL] [Abstract][Full Text] [Related]
19. [Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.].
Urbieta Anza A; Llarena Ibarguren R; Tomás Zabala Egurrola JA; Gutierrez Zurimendi G; Iturregui Del Pozo AM; Arruza Echevarria A
Arch Esp Urol; 2018 Nov; 71(9):757-764. PubMed ID: 30403378
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous ultrasound-guided radiofrequency ablation treatment and genetic testing for renal cell carcinoma with Von Hippel-Lindau disease.
Gao Y; Xu M; Xu ZF; Liu DW; Tu XA; Zheng YL; Wang DH; Sun XZ; Zheng FF; Qiu SP; Lü MD; Zhang YY; Xie XY; Deng CH
J Xray Sci Technol; 2012; 20(1):121-9. PubMed ID: 22398592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
